Syndicated Research Studies

Pediatric Home Healthcare Market Summary The global pediatric home healthcare market was valued at USD 38.32 billion in 2023 and is expected to reach USD 65.1 billion by 2030, registering a CAGR of 7.9% from 2024 to 2030. Market growth is being driven by the increasing adoption of advanced medical technologies that enable continuous and specialized care for children with medical complexities (CMC) within home settings. Home-based pediatric healthcare solutions support life-sustaining treatments in a familiar and comfortable environment, helping reduce prolonged hospital stays for infants and children suffering from respiratory disorders, neurological conditions, and complex cardiac diseases. According to the National Survey of Children with Special Healthcare Needs, nearly 19.4% of children in the United States, equivalent to 14.1 million children, had special healthcare needs during 2019–2020, highlighting the expanding demand for home-based pediatric medical services. The ri...

Pea Starch Market Summary The global pea starch market was valued at USD 91.7 million in 2023 and is projected to reach USD 203.6 million by 2030, expanding at a CAGR of 12.1% from 2024 to 2030. One of the primary factors supporting market growth is the increasing consumer preference for gluten-free products, driven by the rising incidence of celiac disease and gluten intolerance worldwide. Pea starch is gaining traction due to its broad applicability across multiple industries, including food and beverages, pet food, and pharmaceuticals. Its functional benefits—such as high dietary fiber content, notable protein presence, and clean-label positioning—are strengthening its adoption in health-focused formulations. Growing awareness of these nutritional and functional advantages is expected to further boost demand over the forecast period. Shifting dietary habits are also playing a crucial role in market expansion. The rise in vegetarian and vegan lifestyles, fueled by heal...

Patient Monitoring Devices Market Summary The global patient monitoring devices market was valued at USD 50.36 billion in 2024 and is projected to reach USD 118.21 billion by 2033, expanding at a CAGR of 10.21% from 2025 to 2033. Market growth is driven by the rising demand for devices capable of measuring, recording, and displaying vital biometric parameters such as blood pressure, body temperature, and blood oxygen saturation. A rapidly aging global population, coupled with the increasing prevalence of chronic diseases including cardiovascular disorders, diabetes, and respiratory conditions, is a major factor supporting market expansion. According to estimates from the World Health Organization, by 2030, one in six people worldwide will be aged 60 years or older, significantly increasing the need for continuous and long-term health monitoring solutions. This demographic shift is reinforcing the adoption of patient monitoring technologies that enable early diagnosis, timely interve...

Patient-Derived Xenograft Model Market Summary The global patient-derived xenograft (PDX) model market was valued at USD 291.9 million in 2024 and is expected to reach USD 505.3 million by 2030, registering a CAGR of 9.64% from 2025 to 2030. Market growth is largely driven by the rising incidence of cancer worldwide, increased research and development investments by pharmaceutical and biotechnology companies, and continued progress in oncology research and personalized medicine. Conventional cell line-based models often fail to accurately replicate the biological complexity of human tumors, which contributes to high attrition rates in clinical trials. In contrast, PDX models involve the transplantation of patient-derived tumor tissues into immunodeficient mice, allowing them to retain the histological and genetic characteristics of the original tumors. As a result, these models provide a more reliable representation of human cancer biology, making them indispensable tools for precli...

Particle Therapy Market Summary The global particle therapy market was valued at USD 1.54 billion in 2023 and is expected to reach USD 20.61 billion by 2030, expanding at a CAGR of 7.63% from 2024 to 2030. Market expansion is primarily driven by the rising prevalence of cancer worldwide and the increasing demand for advanced, high-precision radiotherapy treatments. Particle therapy has gained significant attention due to its ability to deliver targeted radiation while minimizing damage to surrounding healthy tissues. Cancer continues to pose a substantial global health burden. According to the World Health Organization, approximately 20 million new cancer cases were reported in 2022, resulting in 9.7 million deaths. Additionally, around 53.5 million people survived at least five years following a cancer diagnosis. Nearly one-fifth of the global population is affected by cancer during their lifetime, with approximately 1 in 9 men and 1 in 12 women dying from the disease. Growing awar...

Particle Size Analysis Market Summary The global particle size analysis market was valued at USD 381.0 million in 2022 and is expected to reach USD 578.83 million by 2030, expanding at a CAGR of 5.4% from 2023 to 2030. Market growth is largely driven by extensive research in nanotechnology and increasing demand across industries such as automotive, aerospace, semiconductors, and pharmaceuticals. These sectors rely heavily on precise particle characterization to enhance material performance, product consistency, and manufacturing efficiency. The introduction of advanced particle size analysis techniques offering improved accuracy, flexibility, and system integration capabilities is further supporting market expansion. These technologies enable manufacturers and researchers to develop products with optimized physical and chemical properties, thereby fostering innovation across multiple industrial applications. Enhanced analytical capabilities are increasingly becoming a critical compo...